Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Gastrointestinal Endoscopy
|
February 2, 2016
Adverse events after surgery for nonmalignant colon polyps are common and associated with increased length of stay and costs
Rajesh N Keswani, Ryan Law, Jody D Ciolino, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
Amy A Lo, Andrew Wallace, Daniel Oreper, et al.
The Journal of Molecular Diagnostics : JMD
|
January 26, 2021
Innovative Tumor Tissue Dissection Tool for Molecular Oncology Diagnostics
Manana Javey, Christina Reinsch, Mirjam Feldkamp, et al.
Journal of Visualized Experiments : Jove
|
April 12, 2021
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
Charles A Havnar, Oliver Zill, Jeff Eastham, et al.
Molecular Cancer Therapeutics
|
January 18, 2018
Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
Danielle Mandikian, Nene Takahashi, Amy A Lo, et al.
Cancer Cell
|
May 7, 2021
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
Milena Hornburg, Mélanie Desbois, Shan Lu, et al.
EMBO Reports
|
January 9, 2023
T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction
Patricia Himmels, Thi Thu Thao Nguyen, Maresa Caunt Mitzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Science Translational Medicine
|
October 19, 2018
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3
Dionysos Slaga, Diego Ellerman, T Noelle Lombana, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Gastrointestinal Endoscopy
|
February 2, 2016
Adverse events after surgery for nonmalignant colon polyps are common and associated with increased length of stay and costs
Rajesh N Keswani, Ryan Law, Jody D Ciolino, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
Amy A Lo, Andrew Wallace, Daniel Oreper, et al.
The Journal of Molecular Diagnostics : JMD
|
January 26, 2021
Innovative Tumor Tissue Dissection Tool for Molecular Oncology Diagnostics
Manana Javey, Christina Reinsch, Mirjam Feldkamp, et al.
Journal of Visualized Experiments : Jove
|
April 12, 2021
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
Charles A Havnar, Oliver Zill, Jeff Eastham, et al.
Molecular Cancer Therapeutics
|
January 18, 2018
Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
Danielle Mandikian, Nene Takahashi, Amy A Lo, et al.
Cancer Cell
|
May 7, 2021
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
Milena Hornburg, Mélanie Desbois, Shan Lu, et al.
EMBO Reports
|
January 9, 2023
T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction
Patricia Himmels, Thi Thu Thao Nguyen, Maresa Caunt Mitzner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Science Translational Medicine
|
October 19, 2018
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3
Dionysos Slaga, Diego Ellerman, T Noelle Lombana, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Page
of 3